Natus Medical Incorporated NTUS
$ 31.08
1.94%
Quarterly report 2022-Q1
added 12-23-2023
Natus Medical Incorporated Balance Sheet 2011-2024 | NTUS
Annual Balance Sheet Natus Medical Incorporated
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-64.1 M | -69.5 M | -37.8 M | 48.1 M | 65.3 M | -39.5 M | -82.5 M | -66.6 M | -18.1 M | 9.8 M | -31.9 M |
Long Term Debt |
6.57 M | 5.84 M | 19.7 M | 69.5 M | 154 M | 140 M | - | - | 27.5 M | 13 M | 710 K |
Long Term Debt Current |
4.96 M | 6.78 M | 5.87 M | 35 M | - | - | - | - | 10.5 M | 8.53 M | 188 K |
Total Non Current Liabilities |
- | 43.5 M | 63.6 M | 106 M | 196 M | 152 M | 11.7 M | 13 M | 40 M | 24.5 M | 15.9 M |
Total Current Liabilities |
115 M | 146 M | 143 M | 133 M | 92.1 M | 79.9 M | 77.1 M | 69.1 M | 80.1 M | 98.6 M | 40.7 M |
Total Liabilities |
140 M | 189 M | 206 M | 240 M | 288 M | 232 M | 88.8 M | 82.1 M | 120 M | 123 M | 56.6 M |
Deferred Revenue |
25.1 M | 21.3 M | 20.2 M | 17.1 M | 15.2 M | 23.3 M | 11.3 M | 11.7 M | 12.9 M | 13.3 M | 7.6 M |
Retained Earnings |
84.5 M | 71.3 M | 87.9 M | 102 M | 129 M | 149 M | 107 M | 68.9 M | 34.5 M | 11.6 M | 7.17 M |
Total Assets |
564 M | 600 M | 623 M | 638 M | 710 M | 649 M | 479 M | 435 M | 426 M | 392 M | 314 M |
Cash and Cash Equivalents |
75.6 M | 82.1 M | 63.3 M | 56.4 M | 89 M | 214 M | 82.5 M | 66.6 M | 56.1 M | 23.1 M | 32.8 M |
Book Value |
425 M | 411 M | 416 M | 398 M | 422 M | 417 M | 391 M | 353 M | 306 M | 269 M | 258 M |
Total Shareholders Equity |
425 M | 411 M | 416 M | 398 M | 422 M | 417 M | 391 M | 353 M | 308 M | 270 M | 258 M |
All numbers in USD currency
Quarterly Balance Sheet Natus Medical Incorporated
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 5.76 M | - | - | - | - | 5.84 M | 25.7 M | 51.8 M | 64.7 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 69.5 M | 69.5 M | 69.5 M | 69.5 M | 154 M | 154 M | 154 M | 154 M | 140 M | 140 M | 140 M | 140 M | - | - | - | - | - | 8 M | 6 M | 22.5 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | 13 M | 13 M | 13 M | 13 M | 710 K | 710 K | 710 K | 710 K |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | 137 M | 140 M | 139 M | 138 M | 172 M | 189 M | 201 M | 225 M | 249 M | 206 M | 206 M | 206 M | 206 M | 240 M | 240 M | 240 M | 240 M | 288 M | 288 M | 288 M | 288 M | 232 M | 232 M | 232 M | 232 M | 88.8 M | 88.8 M | 88.8 M | 88.8 M | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 121 M | 120 M | 120 M | 120 M | 123 M | 123 M | 123 M | 123 M | 56.5 M | 56.6 M | 56.6 M | 56.6 M |
Deferred Revenue |
- | - | - | 26.8 M | 25.1 M | 25.7 M | 24.5 M | 23.7 M | 21.3 M | 20 M | 21.2 M | 22.8 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M |
Retained Earnings |
- | - | - | 86.4 M | 84.5 M | 82.7 M | 77.2 M | 73.7 M | 71.3 M | 66.1 M | 75.4 M | 84.3 M | 87.9 M | 87.9 M | 87.9 M | 87.9 M | 102 M | 102 M | 102 M | 102 M | 129 M | 129 M | 129 M | 129 M | 149 M | 149 M | 149 M | 149 M | 107 M | 107 M | 107 M | 107 M | 68.9 M | 68.9 M | 68.9 M | 68.9 M | 36.4 M | 34.5 M | 34.5 M | 34.5 M | 13.3 M | 11.6 M | 11.6 M | 11.6 M | 9.44 M | 7.17 M | 7.17 M | 7.17 M |
Total Assets |
- | - | - | 568 M | 564 M | 561 M | 556 M | 581 M | 600 M | 597 M | 621 M | 647 M | 623 M | 623 M | 623 M | 623 M | 638 M | 638 M | 638 M | 638 M | 710 M | 710 M | 710 M | 710 M | 649 M | 649 M | 649 M | 649 M | 479 M | 479 M | 479 M | 479 M | 435 M | 435 M | 435 M | 435 M | 429 M | 426 M | 426 M | 426 M | 392 M | 392 M | 392 M | 392 M | 315 M | 314 M | 314 M | 314 M |
Cash and Cash Equivalents |
- | - | - | 84.3 M | 75.6 M | 68.8 M | 62.5 M | 80.5 M | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 63.3 M | 63.3 M | 63.3 M | 63.3 M | 56.4 M | 56.4 M | 56.4 M | 56.4 M | 89 M | 89 M | 89 M | 89 M | 214 M | 214 M | 214 M | 214 M | 82.5 M | 82.5 M | 82.5 M | 82.5 M | 66.6 M | 66.6 M | 66.6 M | 66.6 M | 56.1 M | 56.1 M | 56.1 M | 56.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 32.8 M | 32.8 M | 32.8 M | 32.8 M |
Book Value |
- | - | - | 431 M | 425 M | 423 M | 418 M | 409 M | 411 M | 395 M | 395 M | 398 M | 416 M | 416 M | 416 M | 416 M | 398 M | 398 M | 398 M | 398 M | 422 M | 422 M | 422 M | 422 M | 417 M | 417 M | 417 M | 417 M | 391 M | 391 M | 391 M | 391 M | 353 M | 353 M | 353 M | 353 M | 308 M | 306 M | 306 M | 306 M | 269 M | 269 M | 269 M | 269 M | 258 M | 258 M | 258 M | 258 M |
Total Shareholders Equity |
- | - | - | 431 M | 425 M | 423 M | 418 M | 409 M | 411 M | 395 M | 395 M | 398 M | 416 M | 405 M | 416 M | 416 M | 398 M | 398 M | 398 M | 398 M | 422 M | 422 M | 422 M | 422 M | 417 M | 417 M | 417 M | 417 M | 391 M | 391 M | 391 M | 391 M | 353 M | 353 M | 353 M | 353 M | 308 M | 306 M | 306 M | 306 M | 270 M | 269 M | 269 M | 269 M | 260 M | 258 M | 258 M | 258 M |
All numbers in USD currency